The variation in what commercial insurers pay for identical hospital procedures across American metropolitan areas is not a measurement artifact. It is a signal about underlying economic conditions that macro-oriented healthcare investors have barely begun to exploit.
A knee replacement that costs a commercial payer $35,000 in Minneapolis costs $65,000 in Miami and $80,000 in San Francisco—not because the procedures are clinically different, not because outcomes are better in high-cost markets, but because the market structures in which prices are set are fundamentally different. Minneapolis has a health plan duopoly (BCBS Minnesota and HealthPartners) with sufficient leverage to resist hospital rate demands. Miami has fragmented payer markets and a hospital landscape shaped by HCA’s regional dominance. San Francisco has both high labor costs and dominant academic systems with formidable negotiating leverage. These are not idiosyncratic features—they are documented in the Health Care Cost Institute’s geographic variation research and they are stable over time.
MedPricer.org’s rate data, queryable by metropolitan statistical area, makes this geographic dispersion systematically accessible. A fund with macro-oriented healthcare exposure—say, a position in regional hospital systems, regional managed care plans, or commercial real estate with healthcare tenant concentration—can use MedPricer’s geographic rate data as one component of a regional economic analysis.
The mechanism runs in several directions. High hospital rates in a commercial market increase employer health benefit costs, reducing wage growth in tight labor markets and compressing profit margins in industries with high benefit-to-wage ratios. Over time, persistently high health benefit costs may influence employer location decisions—not dramatically, but at the margin, which is where macro signals operate. Conversely, markets with low hospital rates and efficient payer market structures may retain economic activity that would otherwise migrate to lower-cost geographies.
This analysis intersects with the private equity real estate thesis around medical office buildings. MOBs in high-rate hospital markets command premium rents, partly because the healthcare tenants occupying them generate revenue from procedures priced at above-average commercial rates. A fund evaluating MOB portfolios in specific geographies can use MedPricer data to assess whether the underlying procedure economics support the rental rate assumptions embedded in acquisition proformas.
For a macro healthcare investor, geographic rate dispersion data has several potential applications: identifying regional hospital system equities that are priced at national averages despite local rate environments that are above or below average; assessing healthcare REIT portfolios for exposure to high-rate versus low-rate geographies; and evaluating managed care company geographic concentration relative to their market-specific cost structures.
The limitation is that geographic rate data from MedPricer reflects point-in-time disclosed rates rather than actual claims experience, and the relationship between disclosed rates and actual claims costs involves adjustment for payer mix, procedure coding practices, and utilization patterns. Using geographic rate data as a macro signal requires layering it with other regional economic and healthcare market data—a multi-source analytical task that is nontrivial but tractable for a well-resourced healthcare investment team.
